Fennec Pharmaceuticals (FENC) Enterprise Value (2016 - 2025)
Fennec Pharmaceuticals (FENC) has disclosed Enterprise Value for 15 consecutive years, with -$21.9 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Enterprise Value rose 45.57% year-over-year to -$21.9 million, compared with a TTM value of -$21.9 million through Sep 2025, up 45.57%, and an annual FY2024 reading of -$26.6 million, down 100.72% over the prior year.
- Enterprise Value was -$21.9 million for Q3 2025 at Fennec Pharmaceuticals, up from -$22.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$12.4 million in Q3 2023 and bottomed at -$51.2 million in Q1 2024.
- Average Enterprise Value over 5 years is -$26.2 million, with a median of -$23.8 million recorded in 2022.
- The sharpest move saw Enterprise Value tumbled 285.74% in 2024, then soared 55.7% in 2025.
- Year by year, Enterprise Value stood at -$27.3 million in 2021, then grew by 12.89% to -$23.8 million in 2022, then soared by 44.19% to -$13.3 million in 2023, then crashed by 100.72% to -$26.6 million in 2024, then grew by 17.6% to -$21.9 million in 2025.
- Business Quant data shows Enterprise Value for FENC at -$21.9 million in Q3 2025, -$22.7 million in Q1 2025, and -$26.6 million in Q4 2024.